CML Publications July 2025
As part of our monthly news service we would like to make you aware of the CML publications of the month. From the many papers published every month Professor Timothy Hughes has selected topical, interesting papers for your perusal that also include interesting publications from low- and middle-income countries.
Clinical CML papers
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
Apperley JF et al. Leukemia, July 2025 (epub ahead of publication)
open access publication
Improving chronic myeloid leukemia management and quality of life:
Patient and physician survey of unmet needs from the CML SUN Study
Lang F et al. Haematologica, July 2025 (epub ahead of publication)
open access publication
Management of chronic myeloid leukemia in 2025 - Review
Kantarjian H et al. Cancer, July 2025
open access publication
Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus
Giai V et al. Cancer, July 2025
open access publication
Advancing quality of life in chronic myeloid leukemia: Where do we stand?
Lipton JH. Haematologica, July 2025 (epub ahead of print)
Potential therapeutic targets in chronic myeloid leukemia - Review
Bansal M and Varma M. Med Oncol, July 2025
How will genomic testing impact a clinician’s choice for managing chronic myeloid leukemia?
Sia J and Shanmunagathan N. Expert Rev Hematol, July 2025 (epub ahead of print)
Secondary malignancies after chronic myeloid leukemia upon TKI treatment: Population trends and outcomes
Zu Y et al. Br J Haematol, July 2025 (epub ahead of print)
open access publication
Gene expression analysis of patients with chronic myeloid leukemia who discontinued tyrosine kinase inhibitors
Park H et al. Ann Hematol, July 2025 (epub ahead of print)
open access publication
The incidence of vascular adverse events and usefulness of novel risk assessment tool of Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Watanabe et al. Cardiooncology, July 2025
open access publication
Reconstructing CML guidelines for first line treatment from two different points of view
Gambacorti-Passerini C et al. Blood Cancer J, July 2025
open access publication
Scientific CML papers
Preclinical characterization of TGRX-678, a brain-penetrant allosteric inhibitor of BCR::ABL1
Shi Y et al. Blood, July 2025 (epub ahead of print)
Pediatric CML papers
Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemia
Krizkova J et al. Leukemia, July 2025
open access publication
Long-term endocrine outcomes and quality of life in pediatric and young chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: A prospective study from India
Mohan R et al. Front Oncol, July 2025
open access publication
LMIC CML Papers
Introducing diagnostic testing for chronic myeloid leukemia in a public hospital setting in Western Kenya
Orido M et al. Arch Pathol Lab Med, July 2025
open access publication
Budget impact analysis of treatment-free remission in chronic myeloid leukemia patients treated with nilotinib in Tunisia
Hizem A et al. J Cancer Policy, July 2025 (epub ahead of print)